Q2 FY2026 · ended Jun 30, 2026 · Revenue $30.64M, -1.9% YoY · Filed Aug 7, 2026
Orasure Technologies, Inc (OSUR) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $30.6 million and net income of $6.2 million. Free cash flow was -$12.3 million. As of Jun 30, 2026 it held $160.6 million in cash and investments and $12.1 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OSUR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bethlehem, PA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1116463
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $30.6M | $27.9M | $26.8M | $27.1M | $31.2M |
| Operating income | $5.4M | -$23.3M | -$20.1M | -$16.1M | -$18.0M |
| Net income | $6.2M | -$22.4M | -$19.3M | -$13.7M | -$19.7M |
| Diluted EPS | $0.09 | -$0.32 | -$0.27 | -$0.19 | -$0.26 |
| Operating cash flow | -$9.9M | -$13.9M | -$9.0M | -$10.1M | -$10.2M |
| Free cash flow | -$12.3M | -$14.8M | -$9.9M | -$11.0M | -$12.2M |
| Total assets | $360.6M | $379.2M | $403.2M | $423.1M | $445.0M |
| Total liabilities | $42.8M | $65.8M | $62.3M | $61.1M | $64.3M |
| Stockholders' equity | $317.8M | $313.3M | $340.8M | $362.0M | $380.7M |
| Cash and investments | $160.6M | $177.0M | $199.3M | $216.5M | $234.6M |
| Total debt | $12.1M | $12.7M | $13.2M | $13.5M | $14.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 3, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
All 1000 Orasure Technologies, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.